LLM Augmented Intervenable Multimodal Adaptor for Post-operative Complication Prediction in Lung Cancer Surgery explores MIRACLE predicts postoperative complications in lung cancer surgeries using multimodal data and LLM explanations for actionable insights.. Commercial viability score: 8/10 in Healthcare AI.
Use an AI coding agent to implement this research.
Lightweight coding agent in your terminal.
Agentic coding tool for terminal workflows.
AI agent mindset installer and workflow scaffolder.
AI-first code editor built on VS Code.
Free, open-source editor by Microsoft.
6mo ROI
2-4x
3yr ROI
10-20x
Lightweight AI tools can reach profitability quickly. At $500/mo average contract, 20 customers = $10K MRR by 6mo, 200+ by 3yr.
References are not available from the internal index yet.
Breakdown pending for this paper.
Sources used for this analysis
arXiv Paper
Full-text PDF analysis of the research paper
GitHub Repository
Code availability, stars, and contributor activity
Citation Network
Semantic Scholar citations and co-citation patterns
Community Predictions
Crowd-sourced unicorn probability assessments
Analysis model: GPT-4o · Last scored: 4/2/2026
Generating constellation...
~3-8 seconds
This research is critical for improving postoperative care and decision-making in lung cancer surgeries, an area with high morbidity and mortality, potentially reducing complications and healthcare costs.
Develop a SaaS platform where hospitals can input patient data pre-surgery to estimate complication risks, integrating directly with electronic health records.
Replaces manual risk assessment and improves on black-box ML models by offering enhanced, interpretable, and interactive prediction systems, enabling proactive surgical planning.
The global surgical site infection control market is valued at over $4 billion, with hospitals and surgical centers as primary customers seeking better predictive tools for postoperative care.
A clinical decision support tool for surgeons to predict and mitigate postoperative risks in lung cancer patients, improving surgical outcomes.
The paper presents MIRACLE, a deep learning model integrating clinical data, radiomics, and LLM-generated explanations to predict post-surgery complications. It uses Bayesian networks and a fusion of modalities for accurate and interpretable predictions.
Tested on a dataset of 3,094 patients from Roswell Park Cancer Center, MIRACLE outperformed other models in AUC and sensitivity at relevant false positive rates, demonstrating superior predictive ability.
Potential issues include dataset bias due to ethnic homogeneity and reliance on local CT data processing. Regulatory approvals for clinical use may also pose challenges.